Gefitinib-based PROTAC 3
Cat. No. :YN340098
CAS No. :2230821-27-7
Pack size
price
inventory
5mg
Enquiry
Enquiry
10mg
Enquiry
Enquiry
25mg
Enquiry
Enquiry
50mg
Enquiry
Enquiry
Product Name: | Gefitinib-based PROTAC 3 |
CAS NO.: | 2230821-27-7 |
Chemical Name: | |
Synonyms: | |
Molecular Weight: | 934.51 |
Molecular Formula: | C₄₇H₅₇ClFN₇O₈S |
SMILES: | O=C([C@H]1N(C([C@@H](NC(CCOCCOCCCCCOC2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2OC)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC5=CC=C(C6=C(C)N=CS6)C=C5 |
Storage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
Transportation: | Room temperature in continental US; may vary elsewhere. |
Description: | Gefitinib-based PROTAC 3, conjugating an EGFR binding element to a VHL lig and via a linker, inducesEGFRdegradation withDC50s of 11.7nM and 22.3nM in HCC827(exon 19 del) and H3255 (L858R mutantion) cells, respectively. |
IC50&Target: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: | |
References: |
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.